Neurotrophic Keratitis Clinical Trials

28 clinical trials for Neurotrophic Keratitis across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis — RECRUITING · PHASE2
• A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis — RECRUITING · PHASE2
• A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis — RECRUITING · PHASE1
• Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease — RECRUITING · PHASE4
• Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis — RECRUITING · PHASE2
• A MULTI-CENTER, RANDOMIZED, DOUBLE-MASKED, VEHICLE-CONTROLLED, PARALLEL-GROUP, STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CSB-001 OPHTHALMIC SOLUTION 0.1% IN STAGE 2 AND 3 NEUROTROPHIC KERATITIS (NK) SUBJECTS — RECRUITING
• Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects — COMPLETED · PHASE1
• A Study of STSP-0902 Ophthalmic Solution in Healthy Subjects — COMPLETED · PHASE1
• QST for Corneal Nerve Function — SUSPENDED · NA
• DEFENDO Long Term Follow-up Study in Stage 1 NK Patients — COMPLETED
• Study to Evaluate OXERVATE® in Patients With Stage 1 Neurotrophic Keratitis — COMPLETED · PHASE4
• Corneal Neurotization vs. Cenergermin for Neurotrophic Keratitis: A Pilot Study — NOT_YET_RECRUITING · NA
• REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients — COMPLETED · PHASE2
• DOMPE -MT Neurotrophic Keratitis — ACTIVE_NOT_RECRUITING · PHASE4
• Corneal Nerves After Treatment With Cenegermin — COMPLETED
• Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis — WITHDRAWN · PHASE4
• Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry Eye — TERMINATED
• Open-label Trial to Evaluate Efficacy and Safety of rhNGF on Corneal Thickness Via AS-OCT in Neurotrophic Keratitis — WITHDRAWN · PHASE4
• Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis. — COMPLETED · PHASE1
• OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate — OTHER
• Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy. — WITHDRAWN · PHASE2
• Corneal Neurotization as a Treatment for Neurotrophic Keratopathy — TERMINATED · NA
• Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 NK — COMPLETED · PHASE2
• An Investigator-Initiated Study to Assess the Association of Diabetic Retinopathy Severity Scale (DRSS) With Level of Decreased Corneal Sensitivity — OTHER
• Nerve Growth Factor for the Treatment of Cornea Disease — COMPLETED
• TOPICAL INSULIN DROPS FOR THE TREATMENT OF NEUROTROPHIC KERATOPATHY — COMPLETED
• Miniinvasive Corneal Neurotization. A Pilot Study. — TERMINATED · NA
• Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3 — COMPLETED

Refine this search